Related references
Note: Only part of the references are listed.Gemfibrozil and Fenofibrate, Food and Drug Administration-approved Lipid-lowering Drugs, Up-regulate Tripeptidyl-peptidase 1 in Brain Cells via Peroxisome Proliferator-activated Receptor α IMPLICATIONS FOR LATE INFANTILE BATTEN DISEASE THERAPY
Arunava Ghosh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Suppression of Nuclear Factor-κB Activation and Inflammation in Microglia by Physically Modified Saline
Saurabh Khasnavis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Gemfibrozil, a Lipid-lowering Drug, Induces Suppressor of Cytokine Signaling 3 in Glial Cells IMPLICATIONS FOR NEURODEGENERATIVE DISORDERS
Arunava Ghosh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Gemfibrozil, a Lipid-Lowering Drug, Upregulates IL-1 Receptor Antagonist in Mouse Cortical Neurons: Implications for Neuronal Self-Defense
Grant T. Corbett et al.
JOURNAL OF IMMUNOLOGY (2012)
Sodium Benzoate, a Metabolite of Cinnamon and a Food Additive, Upregulates Neuroprotective Parkinson Disease Protein DJ-1 in Astrocytes and Neurons
Saurabh Khasnavis et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2012)
The molecular biology of memory: cAMP, PKA, CRE, CREB-1, CREB-2, and CPEB
Eric R. Kandel
MOLECULAR BRAIN (2012)
Misalignment of PLP/DM20 Transmembrane Domains Determines Protein Misfolding in Pelizaeus-Merzbacher Disease
Ajit Singh Dhaunchak et al.
JOURNAL OF NEUROSCIENCE (2011)
Neuroimmune Pharmacological Control of EAE
Kalipada Pahan
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2010)
Fibrillar Amyloid-β-Activated Human Astroglia Kill Primary Human Neurons via Neutral Sphingomyelinase: Implications for Alzheimer's Disease
Arundhati Jana et al.
JOURNAL OF NEUROSCIENCE (2010)
Sodium Benzoate, a Metabolite of Cinnamon and a Food Additive, Reduces Microglial and Astroglial Inflammatory Responses
Saurav Brahmachari et al.
JOURNAL OF IMMUNOLOGY (2009)
Overexpression of CNTF in Mesenchymal Stem Cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice
Zhengqi Lu et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Proteome Profiling in Murine Models of Multiple Sclerosis: Identification of Stage Specific Markers and Culprits for Tissue Damage
Ralf A. Linker et al.
PLOS ONE (2009)
Signaling through cAMP and cAMP-dependent protein kinase: Diverse strategies for drug design
Susan S. Taylor et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2008)
Risk factors for gastrointestinal complications in aspirin users: Review of clinical and experimental data
Felix W. Leung
DIGESTIVE DISEASES AND SCIENCES (2008)
Oxidative stress kills human primary Oligodendrocytes via neutral sphingomyelinase: Implications for multiple sclerosis
Arundhati Jana et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2007)
Protein kinase C-regulated cAMP response element-binding protein phosphorylation in cultured rat striatal neurons
Li-Min Mao et al.
BRAIN RESEARCH BULLETIN (2007)
Continued administration of ciliary neurotrophic factor protects mice from inflammatory pathology in experimental autoimmune encephalomyelitis
Tanja Kuhlmann et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Sox10 regulates ciliary neurotrophic factor gene expression in Schwann cells
Yasuhiro Ito et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Induction of glial fibrillary acidic protein expression in astrocytes by nitric oxide
S Brahmachari et al.
JOURNAL OF NEUROSCIENCE (2006)
Aspirin-induced blockade of NF-κB activity restrains up-regulation of glial fibrillary acidic protein in human astroglial cells
Moon-Kyoung Bae et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2006)
Intracompartmental delivery of CNTF as therapy for Huntingtons disease and retinitis pigmentosa
DF Emerich et al.
CURRENT GENE THERAPY (2006)
Inhibition of oxygen radical formation by methylene blue, aspirin, or α-lipoic acid, prevents bacterial-lipopolysaccharide-induced fever
W Riedel et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2003)
Signaling from cAMP/PKA to MAPK and synaptic plasticity
R Waltereit et al.
MOLECULAR NEUROBIOLOGY (2003)
CNTF is a major protective factor in demyelinating CNS disease:: A neurotrophic cytokine as modulator in neuroinflammation
RA Linker et al.
NATURE MEDICINE (2002)
Association of a null mutation in the CNTF gene with early onset of multiple sclerosis
R Giess et al.
ARCHIVES OF NEUROLOGY (2002)
Share Paper
